Absorb works by opening a clogged vessel and restoring blood circulation to the heart related to a medication eluting metallic stent, the current standard of care. Absorb then dissolves into the blood vessel, leaving behind a treated vessel that may resume more natural function and movement because it is free of a long lasting metallic implant. Dean Kereiakes, M.D., FACC, FSCAI, medical director of The Christ Medical center Heart & Vascular Middle and the Lindner Analysis Center in Cincinnati, and professor of scientific medicine at Ohio Condition University, was among the first physicians to sign up a patient in to the ABSORB III trial.We are proud to partner with Adeptus Health, stated Patrick T. Ryan, CEO of Press Ganey. This award can be a testament to the firm's leadership in delivering patient-centered care. By achieving and sustaining this degree of excellence, Adeptus Wellness demonstrates their dedication to reducing patient suffering and advancing the entire quality of health care. .. ADAO reaffirms the necessity for banning asbestos The Asbestos Disease Awareness Company today reaffirmed the need for an asbestos ban this Labor Day, as America honors the workforce that continues to power the country, in the wake of the economic depression even.